Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...

Background Up to half of patients with infective endocarditis (IE) require cardiac surgery. Although anaemia is common, its precise prevalence, transfusion practices and impact on outcomes in ...

WO independent directors were sworn in as private sector representatives to the governing board of the Philippine Deposit Insurance Corp. (PDIC) in simple ceremonies on December 19, a statement by the ...

Background Multiple long-term conditions (MLTCs) are common among individuals with heart failure (HF); however, the influence ...

Presence of inherited blindness gene does not guarantee vision loss. Only 28% of carriers develop disease, indicating other ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...

While many use marijuana for managing chronic pain or as a way to unwind at the end of the day, according to UW Medicine, ...

Health-related social needs in HF, removing age from frailty scores, CIED concerns about smartwatches, and more.

A new study challenges what's long been assumed about genetic variants thought to always cause inherited blindness.

Seborrheic dermatitis is associated with other epithelial barrier diseases of the skin and beyond, including the respiratory, ...